Look the company has been brilliant at spin. 10 out of 10.
The problem is that it has failed to live up to sales and profit expectations created by the CEO and shareholders like yourself. I thought when it announced the Resmed deal in May that I may have been wrong but only to find a failure to keep shareholders informed as to why it did not proceed. Such failure to keep shareholders and the market informed demonstrated the risk associated with RNO. Shareholders do not want the truth withheld.
The failure to generate profits means regular capital raisings are required. Always a questionable statement in my opinion as to why they need more funds.
You must agree that all past brokers reports have not matched achievements to date. Guys like you keep on relying that use of products by celebrities will turn your fortunes. I do not share such views. I look on with interest only as a past shareholder who took a loss. No grips about my stance but yes disappointment that it did not take off.
Let me stay away from discussion for a few more weeks. Good luck to all.
RNO Price at posting:
2.9¢ Sentiment: None Disclosure: Not Held
